Paper36969270
Dose-dependent effects of human umbilical cord-derived mesenchymal stem cell treatment in hyperoxia-induced lung injury of neonatal rats.
Xiong J and 6 others. Front Pediatr, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Dose-dependent effects of human umbilical cord-derived mesenchymal stem cell treatment in hyperoxia-induced lung injury of neonatal rats. Papers, record 36969270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969270
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dose-dependent effects of human umbilical cord-derived mesenchymal stem cell treatment in hyperoxia-induced lung injury of neonatal rats.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26378259 | Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice. | Stem Cells Transl Med | 2015 | https://conductscience.org/library/papers/26378259 | PubMed |
| 2 | 17600273 | Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17600273 | PubMed |
| 3 | 16781448 | Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. | Free Radic Biol Med | 2006 | https://conductscience.org/library/papers/16781448 | PubMed |
| 4 | 17656645 | Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Stem Cells | 2007 | https://conductscience.org/library/papers/17656645 | PubMed |
| 5 | 24669883 | Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. | Am J Respir Cell Mol Biol | 2014 | https://conductscience.org/library/papers/24669883 | PubMed |
| 6 | 32587658 | Club Cell Heme Oxygenase-1 Deletion: Effects in Hyperoxia-Exposed Adult Mice. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32587658 | PubMed |
| 7 | 21285513 | The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21285513 | PubMed |
| 8 | 12475808 | Oxidant-antioxidant balance in acute lung injury. | Chest | 2002 | https://conductscience.org/library/papers/12475808 | PubMed |
| 9 | 25970824 | Bone marrow-derived mesenchymal stem cells attenuate phosgene-induced acute lung injury in rats. | Inhal Toxicol | 2015 | https://conductscience.org/library/papers/25970824 | PubMed |
| 10 | 9670828 | Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. | Hum Pathol | 1998 | https://conductscience.org/library/papers/9670828 | PubMed |
| 11 | 18566384 | Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma. | J Immunol | 2008 | https://conductscience.org/library/papers/18566384 | PubMed |
| 12 | 14990357 | Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. | Free Radic Biol Med | 2004 | https://conductscience.org/library/papers/14990357 | PubMed |
| 13 | 28214990 | Interactions between mesenchymal stem cells and the immune system. | Cell Mol Life Sci | 2017 | https://conductscience.org/library/papers/28214990 | PubMed |
| 14 | 5334613 | Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. | N Engl J Med | 1967 | https://conductscience.org/library/papers/5334613 | PubMed |
| 15 | 27095254 | Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. | Cell Biol Toxicol | 2016 | https://conductscience.org/library/papers/27095254 | PubMed |
| 16 | 31357692 | Mesenchymal Stem Cell Migration and Tissue Repair. | Cells | 2019 | https://conductscience.org/library/papers/31357692 | PubMed |
| 17 | 20055707 | Mechanisms of cell protection by heme oxygenase-1. | Annu Rev Pharmacol Toxicol | 2010 | https://conductscience.org/library/papers/20055707 | PubMed |
| 18 | 16314469 | Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. | Am J Pathol | 2005 | https://conductscience.org/library/papers/16314469 | PubMed |
| 19 | 36157523 | Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways. | World J Stem Cells | 2022 | https://conductscience.org/library/papers/36157523 | PubMed |
| 20 | 28774314 | Surfactant effects on the viability and function of human mesenchymal stem cells: in vitro and in vivo assessment. | Stem Cell Res Ther | 2017 | https://conductscience.org/library/papers/28774314 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599232 | Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599232 | PubMed |
| 40698659 | Protective mechanisms of exosomes derived from human umbilical cord mesenchymal stem cells in bronchopulmonary dysplasia. | Physiol Res | 2025 | https://conductscience.org/library/papers/40698659 | PubMed |
| 40034220 | Safety, Efficacy and Bio-Distribution Analysis of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells for Effective Treatment of Bronchopulmonary Dysplasia by Intranasal Administration in Mice Model. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40034220 | PubMed |
| 39449014 | Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia. | Respir Res | 2024 | https://conductscience.org/library/papers/39449014 | PubMed |
| 37965579 | Mesenchymal stromal/stem cells and bronchopulmonary dysplasia. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37965579 | PubMed |
| 37380752 | Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022). | Pediatr Res | 2023 | https://conductscience.org/library/papers/37380752 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969270
GET https://conductscience.org/api/papers/v1/36969270/references?page=2